Comparative study of population pharmacokinetics upon switching of cyclosporine formulation from sandimmune to neoral in stable renal transplant patients

By Yoshida K.   Kimura T.   Hamada Y.   Saito T.   Endo T.   Baba S.   Shimada S.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3146-3147

Elsevier

Access to resources Recommend Favorite

A critical appraisal of cyclosporine a pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (neoral)

By Foradori A.   Pinto V.M.   Elberg A.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1666-1667

Elsevier

Access to resources Recommend Favorite

Impact of cyclosporine dosing frequency on graft function and survival after the conversion from sandimmun to neoral in stable kidney transplanted patients

By Sampaio E.L.M.   Park S.I.   Felipe C.R.   Silva H.T.   Pestana J.O.M.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3153-3161

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients

By Fisher R.A.   Pan S.-H.   Rossi S.J.   Schroeder T.J.   Irish W.D.   Canafax D.M.   Lopez R.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 394-395

Elsevier

Access to resources Recommend Favorite

Conversion From Cyclosporine Sandimmune to Cyclosporine Neoral in the Stable Renal Transplant Population

By Griffin P.J.A.   Moore R.H.   Jurewicz W.A.   Lord R.H.H.   Webley Y.   Jenkins J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 303-303

Elsevier

Access to resources Recommend Favorite